Korro Bio, Inc. Share Price

Korro Bio, Inc. Share Price

NASDAQ: KRRO | Micro Cap
$12.38
-$0.30 (-2.41%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Korro Bio, Inc. Stock Performance

Open
$12.66
Prev. Close
$12.68
Circuit Range
N/A
Day Range
$12.20 - $12.66
Year Range
$5.21 - $17.14
Volume
3,611
Average Traded
$12.34

Korro Bio, Inc. Share Price Today

As of 18 November 2026, Korro Bio, Inc.'s share price is $12.38. The stock opened at $12.66, compared to its previous close of $12.68. During today's trading session, Korro Bio, Inc.'s share price traded between $12.20 and $12.66, with an average price of $12.43. Over the past 52 weeks, the stock has recorded a high of $17.14 and a low of $5.21. In terms of performance, Korro Bio, Inc.'s share price has declined by 7.82% over the last six months and is up 117.11% on a year-on-year basis.

Korro Bio, Inc. Share Price Chart

Line chart of the Korro Bio, Inc. price trend over the selected period. The price fell overall, ranging from 12.16 to 13.14, ending at 12.38.
$12.20$12.66
L
Show Current Price
H

Korro Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$116.27M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-7.73
Revenue (TTM)
$6.39B
Return On Equity (TTM)
-120.09%
Profit Margin
-1835.05%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
64.93%

Korro Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.29$0.00$0.00$0.00
Net Profit-$50.04-$19.63-$18.92-$17.55
Net Profit Margin-3879.07%N/AN/AN/A
Income ChangeN/A60.77%3.62%7.24%

Korro Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$2.27$6.39
Net Profit-$81.17-$83.58-$117.26
Net Profit MarginN/A-3681.94%-1835.05%
Income ChangeN/A-2.97%-40.30%

About Korro Bio, Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Korro Bio, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$14.15
$12.32
-14.09%
Oct 2026
$9.79
$14.34
+45.58%
Sep 2026
$12.50
$9.85
-25.66%
Aug 2026
$10.69
$13.25
+28.27%
Jul 2026
$13.11
$10.33
-21.27%
Jun 2026
$13.10
$13.12
-2.27%
May 2026
$13.27
$13.43
+1.02%
Apr 2026
$11.76
$13.29
+17.20%
Mar 2026
$11.55
$11.34
-4.79%
Feb 2026
$13.26
$11.91
-10.59%
Jan 2026
$7.99
$13.32
+66.08%
Dec 2025
$5.54
$8.02
+40.70%

KRRO Share Price FAQs